Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation

NCT00080873 is registered in ClinicalTrials.gov with Children's Oncology Group as lead sponsor.

NCT NCT00080873
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00080873 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Randomized Double Blind Placebo Controlled Clinical Trial to Assess the Efficacy of Traumeel® S (IND#66649) for the Prevention and Treatment of Mucositis in Children Undergoing Hematopoietic Stem Cell Transplantation
Lead sponsor
Children's Oncology Group
Phase
Not applicable
Overall status
Completed
Start date
April 30, 2004
Completion date
January 31, 2011
Enrollment
195 (actual)
Sites
44

Conditions

As the registry lists them; a condition with its own page is linked.

kidney cancer, leukemia, lymphoma, neuroblastoma, oral complications, sarcoma